FGF19 and hepatocellular carcinoma: Desnoyers et al produced a neutralizing anti-FGF19 monoclonal antibody which prevented development of HCC in FGF19 transgenic mice that were treated with diethylnitrosamine which can accelerate tumour progression [55].